alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.2





Exhibit 10.2




REVOLVING NOTE




August 31, 2010




For value received, the undersigned, DESTRON FEARING CORPORATION, a Delaware corporation (the
“Borrower”), hereby promises to pay ON DEMAND, and if demand is not made, then as provided in the
Credit Agreement (defined below), to the order of TCI BUSINESS CAPITAL, INC., a Minnesota
corporation (the “Lender”) on the Termination Date referenced in the Credit and Security Agreement
dated the same date as this Revolving Note that was entered into by the Lender and the Borrower (as
amended from time to time, the “Credit Agreement”), at Lender’s office located at 12270 Nicollet
Avenue South, Burnsville, Minnesota, 55337, or at any other place designated at any time by the
holder hereof, in lawful money of the United States of America and in immediately available funds,
the principal sum of Four Million and 00/100 Dollars ($4,000,000.00) or, if less, the aggregate
unpaid principal amount of all Advances made by the Lender to the Borrower under the Credit
Agreement, together with interest on the principal amount hereunder remaining unpaid from time to
time, computed on the basis of the actual number of days elapsed and a 360-day year, from the date
hereof until this Revolving Note is fully paid at the rate from time to time in effect under the
Credit Agreement.



This Revolving Note is the Revolving Note referenced in the Credit Agreement, and is subject
to the terms of the Credit Agreement, which provides, among other things, for acceleration hereof.
Principal and interest due hereunder shall be payable as provided in the Credit Agreement, and this
Revolving Note may be prepaid only in accordance with the terms of the Credit Agreement. This
Revolving Note is secured, among other things, pursuant to the Credit Agreement and the Security
Documents as therein defined, and may now or hereafter be secured by one or more other security
agreements, assignments or other instruments or agreements.



The Borrower shall pay all costs of collection, including reasonable attorneys’ fees and legal
expenses if this Revolving Note is not paid when due, whether or not legal proceedings are
commenced.




Presentment or other demand for payment, notice of dishonor and protest are expressly waived.



	 	 	 	 	 	 	 	 	 
	 	 	DESTRON FEARING CORPORATION,	 	 
	 	 	a Delaware corporation	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	By:	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 	 	 	 	Jason Prescott	 	 
	 

	 	 	 	Its:
	 	Chief Financial Officer
**Exhibit 31.2****Certification**I, Patrick C. Greenwell, certify that:1. I have reviewed this Quarterly Report on Form 10-Q of First Advantage Bancorp; 2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report; 3. Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport; 4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision, toensure that material information relating to the registrant, including itsconsolidated subsidiaries, is made known to us by others within those entities,particularly during the period in which this report is being prepared;  (b) Evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end of theperiod covered by this report, based on such evaluation; and  (c) Disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’s mostrecent fiscal quarter (the registrant’s fourth fiscal quarter in the case of anannual report) that has materially affected, or is reasonably likely tomaterially affect, the registrant’s internal control over financial reporting;and5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of the registrant’s Board of Directors (or persons performing the equivalentfunctions): (a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and  (b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internal controlover financial reporting.Dated:November 21, 2007                                      /s/ Patrick C. Greenwell   Patrick C. Greenwell   Chief Financial Officer
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

CARLOS TORRES AND ILONA BAIR,

Petitioners

v.

BRENNTAG NORTHEAST, INC.; 

ARMSTRONG WORLD INDUSTRIES, INC.; 

BARLEY SNYDER, LLP; AND ALAN J. 

HAY, MD,

Respondents

:

:

:

:

:

:

:

:

:

:

:

:

:

:

No. 241 MAL 2021

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 18th day of May, 2022, the Petition for Allowance of Appeal is 

DENIED.
Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

The undersigned manager of NGA HoldCo, LLC (the Company) hereby certifies to his
knowledge that the Companys quarterly report on Form 10-Q for the period ended September 30, 2008 (the Report), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of
Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.



|                        |  |                              
|----------------------- |  | -----------------------------
|Date: November 26, 2008 |  | /s/ Roger A. May             
|                        |  | Roger A. May                 
|                        |  | Manager                      
|                        |  | (Principal Financial Officer)
# C_2005186EN.01000401.xml

| 29.7.2005 | EN | Official Journal of the European Union | C 186/4 |
| --- | --- | --- | --- |

29.7.2005

EN

Official Journal of the European Union

C 186/4

---

Corrigendum to the summary of Community decisions on marketing authorisations in respect of medicinal products from 10 May 2005 to 15 June 2005

(Decision taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decision taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(
  Official Journal of the European Union C 153 of 24 June 2005
  )

(
  Official Journal of the European Union C 153 of 24 June 2005

(2005/C 186/03)

On page 6, in the table, second column:

for:

for:

‘Regividon’,

read:

read:

‘Rigevidon’.

---
Exhibit 13.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ENACTED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 20-F of Companhia Energética de Minas GeraisCEMIG (the
Company) for the period ended December 31, 2017, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Bernardo Afonso Salomão de Alvarenga, Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



By:

/s/ Bernardo Afonso Salomão de AlvarengaName: Bernardo Afonso Salomão de AlvarengaTitle: Chief Executive Officer


Date: May 7, 2018
FOIA CONFIDENTIAL TREATMENT REQUEST

April 28, 2023

VIA ELECTRONIC PORTAL

Assistant Secretary of the CFTC

for FOIA, Privacy and Sunshine Acts Compliance 

Three Lafayette Centre

1155 21st Street, NW

Washington, DC 20581

Re: Weekly Notification of Rule Amendments – Updates to Risk Parameters Established by ICC 

Pursuant to Section 5c(c)(1) of the Commodity Exchange Act and Commission Regulation 

40.6(d)

Dear Assistant Secretary:

In conjunction with the notice submitted by ICE Clear Credit LLC (“ICC”) today, March 24, 2023, to the 

Secretary of the Commodity Futures Trading Commission (“Commission”), pursuant to Section 5c(c)(1) of 

the Commodity Exchange Act and Commission Regulation 40.6(d), ICC submits the attached confidential 

documents. 

The attached documents contain updated risk parameters established by ICC in consultation with the ICC 

Risk Committee, Trading Advisory Group and/or Risk Working Group. During the week ending April 28, 

2023, changes were made to the following parameters: 

• recovery rate for a European risk factor

***********************

Under the Freedom of Information Act (“FOIA”), 5 USC Section 552, Section 809(g) of the Dodd-Frank Wall 

Street Reform and Consumer Protection Act and pursuant to Commission Regulation 145.9(d), Federal 

Reserve Board Regulation 261.15 and any other applicable regulations under or implementing FOIA, ICE 

Clear Credit hereby respectfully requests that confidential treatment be maintained for the document which 

bear Bates number 04.28.2023-000001-CFTC1 until further notice. In accordance with Commission 

Regulation 145.9(d)(4), every page of the confidential information bears the designation “Confidential 

Treatment Requested by ICE Clear Credit LLC.” 

ICE Clear Credit also requests that the Commission or the Board notify the undersigned immediately after 

receiving any FOIA request for such documents or any other court order, subpoena or summons for the 

same. Finally, ICE Clear Credit requests that it be notified in the event the Commission or the Board intends 

to disclose such documents to Congress or to any other governmental agency or unit pursuant to Section 8 

of the Commodity Exchange Act, as amended (“CEA”) or other applicable law. ICE Clear Credit does not 

waive its notification rights under Section 8(f) of the CEA or other applicable law with respect to any 

subpoena or summons for such document(s).

The basis for the request is that disclosure of these document(s) would reveal confidential commercial and 

financial information of ICE Clear Credit, the disclosure of which could have a material adverse effect on, 
and cause injury to, the operations and competitive position of ICE Clear Credit. This request is not to be 

construed as a waiver of any other protection from disclosure or confidential treatment accorded by law, 

and ICE Clear Credit will rely on and invoke any such confidentiality protection.

***********************

Please direct any questions or requests for information to the attention of the undersigned at 

eric.nield@ice.com or (312) 836-6742.

Sincerely,

Eric Nield

General Counsel
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Initial Review Group Subcommittee F—Manpower & Training.                    

*Date:*                         June 13-15, 2001.                    

*Time:*                         8 am to 6 pm.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Holiday Inn—Georgetown, 2101 Wisconsin Avenue, N.W., Washington, DC 20007.                    

*Contact Person:*                         Mary Bell, PhD, Scientific Review Administrator, Grants Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, Phs. Dhhs, 6116 Executive Boulevard, Room 8113, Bethesda, Md 20892-8328, 301-496-7978.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: May 15, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 01-12917 Filed 5-22-01; 8:45 am]

BILLING CODE 4140-01-M
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 224 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 224

   To amend section 1908 of title 41, United States Code, to exempt 
    certain contracts from the periodic inflation adjustments to an 
                 acquisition-related dollar threshold.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 3, 2019

Ms. Velazquez introduced the following bill; which was referred to the 
                   Committee on Oversight and Reform

_______________________________________________________________________

                                 A BILL

 
   To amend section 1908 of title 41, United States Code, to exempt 
    certain contracts from the periodic inflation adjustments to an 
                 acquisition-related dollar threshold.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXEMPTION OF CERTAIN CONTRACTS FROM THE PERIODIC INFLATION 
              ADJUSTMENTS TO THE ACQUISITION-RELATED DOLLAR THRESHOLD.

    Subparagraph (B) of section 1908(b)(2) of title 41, United States 
Code, is amended by inserting ``3131 to 3134,'' after ``sections''.
                                 <all>
```
exv10w1



 






Form of Amendment To Change of Control Agreement




     THIS AMENDMENT is made as of December 22, 2005 by and between Animas Corporation (the
“Company”) and                      (the “Employee”).



     WHEREAS, the Company and Employee are parties to a Change Of Control Agreement relating to the
Employee’s employment dated as of                      (the “Agreement”);



     WHEREAS, Section 7.8 of the Agreement provides that the parties may agree to amend the
Agreement in writing;



     WHEREAS, the Company and Employee wish to amend the Agreement regarding the timing of the
payments under the Agreement to the extent that such payments are subject to the penalties and
additional tax provisions of Section 409A of the Internal Revenue Code of 1986, as amended; and



     NOW THEREFORE, the parties hereby amend the Agreement effective as of the date hereof as
follows:



     1. Section 7 shall be, and it hereby is, amended with the addition of a new subsection to the
end thereof as follows:




	 	 	“7.12. Internal Revenue Code Section 409A. Notwithstanding anything to the
contrary in this Agreement, to the extent required to comply with Section
409A of the Code, if the Employee is deemed to be a “specified employee”
for purposes of Section 409A(a)(2)(B) of the Code, the Employee agrees that
the payments and benefits due to the Employee under this Agreement in
connection with a termination of the Employee’s employment hereunder that
would otherwise have been payable at any time during the six-month period
immediately following such termination of employment shall not be paid
prior to, and shall instead be payable in a lump sum as soon as practicable
following, the expiration of such six-month period. In light of the
uncertainty surrounding the application of Section 409A of the Code, the
Company cannot make any guarantee as to the treatment under Section 409A of
the Code of any payments made or benefits provided under this Agreement.”




 









 




     2. The Agreement, as amended by the foregoing changes, is ratified and confirmed in all
respects.



     IN WITNESS WHEREOF, the Company has caused this Amendment to be executed by its duly
authorized representative, and Employee has executed this Agreement, in each case on the date first
above written.




			
	 	ANIMAS CORPORATION



				
	 	By: 	 	 


				
	 	Name & Title: 	 	 






			
	 	EMPLOYEE
	 
	 	 	 



-2-
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2273 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 2273

 To amend the Internal Revenue Code of 1986 to provide an increasingly 
  larger earned income credit for families with more than 3 children.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 10, 2019

  Mr. Nadler introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To amend the Internal Revenue Code of 1986 to provide an increasingly 
  larger earned income credit for families with more than 3 children.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Tax Fairness for All Families Act of 
2019''.

SEC. 2. INCREASED EARNED INCOME CREDIT FOR FAMILIES WITH MORE THAN 3 
              CHILDREN.

    (a) In General.--Paragraph (1) of section 32(b) of the Internal 
Revenue Code of 1986 is amended to read as follows:
            ``(1) Percentages.--For purposes of subsection (a)--

------------------------------------------------------------------------
 ``In the case of an eligible individual    The  credit    The phaseout
                  with:                   percentage is:  percentage is:
------------------------------------------------------------------------
1 qualifying child......................              34           15.98
2 qualifying children...................              40           21.06
3 qualifying children...................              45           21.06
4 qualifying children...................              50           21.06
5 qualifying children...................              55           21.06
6 qualifying children...................              60           21.06
7 or more qualifying children...........              65           21.06
No qualifying children..................            7.65         7.65''.
------------------------------------------------------------------------

    (b) Effective Date.--The amendment made by this section shall apply 
to taxable years beginning after December 31, 2018.
                                 <all>
```
# C_2017161EN.01004001.xml

| 22.5.2017 | EN | Official Journal of the European Union | C 161/40 |
| --- | --- | --- | --- |

22.5.2017

EN

Official Journal of the European Union

C 161/40

---

Action brought on 4 April 2017 — SSP Europe v EUIPO (SECURE DATA SPACE)

(Case T-205/17)

(2017/C 161/56)

Language of the case: German

Parties

Parties

Applicant: SSP Europe GmbH (Munich, Germany) (represented by: B. Bittner, lawyer)

Applicant:

Defendant: European Union Intellectual Property Office (EUIPO)

Defendant:

Details of the proceedings before EUIPO

Details of the proceedings before EUIPO

Trade mark at issue: EU figurative mark including the word elements ‘SECURE DATA SPACE’ — Application No 14 056 998

Trade mark at issue:

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 27 January 2017 in Case R 2467/2015-5

Contested decision

Form of order sought

Form of order sought

The applicant claims that the Court should:

| — | annul the contested decision (notified on 9 February 2017); |
| --- | --- |

—

annul the contested decision (notified on 9 February 2017);

| — | order EUIPO to pay the costs. |
| --- | --- |

—

order EUIPO to pay the costs.

Pleas in law

Pleas in law

| — | Infringement of Article 7(1)(c) of Regulation No 207/2009; |
| --- | --- |

—

Infringement of Article 7(1)(c) of Regulation No 207/2009;

| — | Infringement of Article 7(1)(b) of Regulation No 207/2009. |
| --- | --- |

—

Infringement of Article 7(1)(b) of Regulation No 207/2009.

---